| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |